Literature DB >> 9629838

Neurological manifestations of falciparum malaria.

C R Newton1, D A Warrell.   

Abstract

Plasmodium falciparum remains one of the most common causes of central nervous system infection worldwide. Recently, differences between the pathophysiology of cerebral malaria in African children and nonimmune adults have been discovered, new syndromes occurring after malaria infection described, and mechanisms for the pathogenesis proposed. In addition, new antimalarial agents have been examined worldwide and initial studies on supportive studies conducted. This paper reviews these new advances, putting them into the perspective of the more established knowledge.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9629838     DOI: 10.1002/ana.410430603

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  24 in total

Review 1.  Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors:  Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 2.  Diagnosis and management of the neurological complications of falciparum malaria.

Authors:  Saroj K Mishra; Charles R J C Newton
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

3.  Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India.

Authors:  Tonya Mixson-Hayden; Vidhan Jain; Andrea M McCollum; Amanda Poe; Avinash C Nagpal; Aditya P Dash; Jonathan K Stiles; Venkatachalam Udhayakumar; Neeru Singh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

4.  Burden of cerebral malaria in central India (2004-2007).

Authors:  Vidhan Jain; Avinash C Nagpal; Pradeep K Joel; Manmohan Shukla; Mrigendra P Singh; Rasik B Gupta; Aditya P Dash; Saroj K Mishra; Venkatachalam Udhayakumar; Jonathan K Stiles; Neeru Singh
Journal:  Am J Trop Med Hyg       Date:  2008-10       Impact factor: 2.345

5.  Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: findings from a prospective cohort study.

Authors:  Gretchen L Birbeck; Nicholas Beare; Susan Lewallen; Simon J Glover; Malcolm E Molyneux; Peter W Kaplan; Terrie E Taylor
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

6.  A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria.

Authors:  Ryan W Carroll; Mark S Wainwright; Kwang-Youn Kim; Trilokesh Kidambi; Noé D Gómez; Terrie Taylor; Kasturi Haldar
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

7.  Heme oxygenase-1 affords protection against noncerebral forms of severe malaria.

Authors:  Elsa Seixas; Raffaella Gozzelino; Angelo Chora; Ana Ferreira; Gabriela Silva; Rasmus Larsen; Sofia Rebelo; Carmen Penido; Neal R Smith; Antonio Coutinho; Miguel P Soares
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

8.  Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children.

Authors:  Richard Idro; Moses Ndiritu; Bernhards Ogutu; Sadik Mithwani; Kathryn Maitland; James Berkley; Jane Crawley; Gregory Fegan; Evasius Bauni; Norbert Peshu; Kevin Marsh; Brian Neville; Charles Newton
Journal:  JAMA       Date:  2007-05-23       Impact factor: 56.272

9.  Cerebrospinal Fluid Studies in Kenyan Children with Severe Falciparum Malaria.

Authors:  N Mturi; G Keir; C A Maclennan; A Ross; A C Willis; B C Elford; J A Berkley; C R J C Newton
Journal:  Open Trop Med J       Date:  2008

10.  Impaired everyday memory associated with encephalopathy of severe malaria: the role of seizures and hippocampal damage.

Authors:  Michael Kihara; Julie A Carter; Penny A Holding; Faraneh Vargha-Khadem; Rod C Scott; Richard Idro; Greg W Fegan; Michelle de Haan; Brian G R Neville; Charles R J C Newton
Journal:  Malar J       Date:  2009-12-01       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.